DEVICE CATEGORY · NPV
Pulmonary Valve Prosthesis Percutaneously Delivered
These devices are intended to replace a patient's pulmonary heart valve. They are different from the classified device (heart valves) in that they are placed percutaneously and do not require open chest surgery or a cardiotomy for placement.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA | |
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
Harmony TPV SystemP200046 | Medtronic, Inc. | PMA approval | Mar 26, 2021 | FDA |
| Edwards Lifesciences, LLC | PMA approval | Aug 31, 2020 | FDA |
Source information
Follow the FDA links to view the original records.



